2021 Mar15;42(2):101-132 6
The Patent Battle That Opened the Door Novo Nordisk filed its semaglutide patent application with Brazil's patent office (INPI) in 2006
Patients should seek prompt medical guidance for severe or persistent vomiting, signs of dehydration, severe abdominal pain, fainting, symptoms of low blood sugar, inability to keep fluids down, worsening constipation with pain or bloating, or any symptom that feels unsafe
Chen TW, Wardill TJ, Sun Y et al (2013) Ultrasensitive fluorescent proteins for imaging neuronal activity
"FDA approves weight management drug"
A recent study found that getting GLP-1 medications online is often almost too easy, with many platforms approving prescriptions in under five minutes and without any meaningful clinician interaction